KalVista Pharmaceuticals, Inc.KALVNASDAQ
LOADING
|||
| Metric | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -41 | 0 | 0 | -86 | 0 |
| Operating Income | -58 | -97↓66.8% | -111↓14.8% | -140↓26.7% | -188↓33.9% |
| Net Income | -46 | -82↓78.1% | -93↓12.8% | -127↓36.3% | -183↓44.9% |
| EBITDA | -57 | -81↓40.7% | -94↓16.9% | -134↓42.3% | -173↓29.1% |
| EPS Diluted | -2.33 | -3.36↓44.2% | -3.33↑0.9% | -3.44↓3.3% | -3.69↓7.3% |